Skip to main content
SpringerLink
Log in

Serotonin in migraine: Theories, animal models and emerging therapies

  • Chapter
Progress in Drug Research

Part of the book series: Progress in Drug Research ((PDR,volume 51))

Summary

A role for serotonin in migraine has been supported by changes in circulating levels of serotonin and its metabolites during the phases of a migraine attack, along with the ability of serotonin-releasing agents to induce migraine-like symptoms. The development of serotonin receptor agonists with efficacy in the clinic for the alleviation of migraine pain further implicates serotonin as a key molecule in migraine.

Several theories regarding the etiology of migraine have been proposed. The vasodilatory theory of migraine suggested that extracranial arterial dilation during an attack was related to migraine pain; a theory supported when vasoconstrictors such as sumatriptan alleviated migraine pain. The neurological theory of migraine proposed that migraine resulted from abnormal firing in brain neurons. Cortical spreading depression, one facet of the neurological theory, could explain the prodrome of migraine. The neurogenic dural inflammation theory of migraine supposed that the dural membrane surrounding the brain became inflamed and hypersensitive due to release of neuropeptides from primary sensory nerve terminals. Substance P, calcitonin gene related peptide and nitric oxide are all though to play a role in the dural inflammatory cascade.

Animal models of migraine have been utilized to study the physiology of migraine and develop new pharmaceutical therapies. One model measures the shunting of blood to arterovenous anastomoses based on a proposal that migraine primarily involves cranial arteriovenous vasodilation. Another model utilizes electrical stimulation of the trigeminal ganglion to indoce neurogenic dural inflammation quantified by the resulting extravasation of proteins. Pharmacological agents such as meta-chlorophenylpiperazine (mCPP) and nitroglycerin have also been used to induce dural extravasation in animals. Both compounds also induce migraine attacks in individuals with a history of migraine. In addition, Fos, a protein produced by activation of the c-fos gene, has been measured as an index of migraine-like pain transmission to the CNS following chemical or electrical stimulation of the trigeminal nerve.

A role for serotonin in migraine is further supported by the efficacy of serotonin receptor ligands. Sumatriptan is an agonist at 5-HT1D and 5-HT1B receptor subtypes, and effective in treating migraine pain and associated symptoms. Recently, selective 5-HT1F agonists have been proposed for the treatment of migraine, without the side effects associated with the present 5-HT1D and 5-HT1B receptor agonists. A role for 5-HT2B receptors has also been suggested in the initiation of migraine, supporting use of selective 5-HT2B receptor antagonists in migraine. Thus, agents that modulate 5-HT1B, 5-HT1D, 5-HT1F and 5-HT2B receptors either have or may have clinical utility in the therapy of migraine headache.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Abbreviations

5-HIAA:

5-hydroxyindole acetic acid

5-HT:

5-hydroxytryptamine (serotonin)

CGRP:

calcitonin gene-related peptide

mCPP:

meta-chlorophenylpiperazine

NO:

nitric oxide

CNS:

central nervous system

L-NAME:

N-nitro-L-arginine methyl ester

References

  1. Sicuteri F., Testi A. and Anselmi B.: Int. Arch. Allergy 19, 55–58 (1961).

    CAS  Google Scholar 

  2. Curran D.A., Hinterberger H. and Lance J.W.: Brain 88, 997–1007 (1965).

    PubMed  CAS  Google Scholar 

  3. Anthony M., Hinterberger H.J. and Lance J.W.: Arch. Neurol. 16, 544–552 (1967).

    PubMed  CAS  Google Scholar 

  4. Ferrari M.D., Odink J., Tapparelli C., Van Kempen G.M.J., Pennings E.S.M. and Bruyn G.W.: Neurology 39, 1239–1242 (1989).

    PubMed  CAS  Google Scholar 

  5. Fozard J.R.: Prog. Pharmacol. 4, 135–146 (1982).

    CAS  Google Scholar 

  6. Griffith S.C. and Burnstock G.: Lancet 1, 561–562 (1983).

    PubMed  CAS  Google Scholar 

  7. Carroll J.D. and Hilton B.T.: Headache 14, 149–156 (1974).

    PubMed  CAS  Google Scholar 

  8. Del Bene E., Anselmi B., Del Bianco P.L., Fanciullacci M., Gali P., Salmon S. and Sicuterri F., in: E Sicuteri (ed.): Headache, new vistas. Biomedical Press, Florence 1977, pp. 101–109.

    Google Scholar 

  9. Graham J.R. and Wolff H.G.: Arch. Neurol. Psychia. 39, 737–763 (1938).

    CAS  Google Scholar 

  10. Nichols E.T., Mawad M. and Mohr J.P.: Stroke 21, 555–559 (1990).

    PubMed  Google Scholar 

  11. Dahl A., Russell D., Nyberg-Hansen R. and Rootwelk K.: Cephalalgia 10, 87–94 (1990).

    PubMed  CAS  Google Scholar 

  12. Kimball R., Friedman A. and Vallejo E.: Neurology 10, 107–111 (1960).

    PubMed  CAS  Google Scholar 

  13. Saxena P.R., in: J.N. Blau (ed.): Migraine — therapeutic, conceptual and research aspects. Elsevier, Amsterdam 1987, pp. 581–596.

    Google Scholar 

  14. Saxena P.R., in: J. Olesen and M.A. Moskowitz (eds.): Experimental headache models in animal and man. Lippincott-Raven Publishers, Philadelphia 1995, 189–198.

    Google Scholar 

  15. Andersen A.R., Freiberg L., Olsen T.S. and Olesen J.: Arch. Neurol. 45, 154–159 (1988).

    PubMed  CAS  Google Scholar 

  16. Ferrari M.D., Haan J., Blokland J.A.K., Arndt J.W., Minnee P., Zwinderman A.H., Pauwels E.K.J. and Saxena P.R.: Arch. Neurol. 52, 135–139 (1995).

    PubMed  CAS  Google Scholar 

  17. Zwetsloot C.P., Caekebeke J.F.V. and Jansen J.C.: Cephalalgia 11, 103–107 (1991).

    PubMed  CAS  Google Scholar 

  18. Zwetsloot C.P., Caebeke J.F.V. and Ferrari M.D.: Stroke 24, 1335–1338 (1993).

    PubMed  CAS  Google Scholar 

  19. Olsen J. and Paulson O.B.: Stroke 2, 148–159 (1971).

    Google Scholar 

  20. Wei E.P., Moskowitz M.A., Boccalini P. and Kontos H.A.: Circ. Res. 70, 1313–1319 (1992).

    PubMed  CAS  Google Scholar 

  21. Goadsby P.J. and Edvinsson L.: Ann. Neurol. 33, 48–56 (1993).

    PubMed  CAS  Google Scholar 

  22. Moskowitz M.A.: Trends Pharmacol. Sci. 13, 307–311 (1992).

    PubMed  CAS  Google Scholar 

  23. Pearce J.M.S.: Lancet 2, 86–89 (1984).

    PubMed  CAS  Google Scholar 

  24. Moskowitz M.A., Nozaki K. and Kraig R.P.: J. Neurosci. 13, 1167–1177 (1993).

    PubMed  CAS  Google Scholar 

  25. Moskowitz M.A.: Neurology 43, S 16–20 (1993).

    Google Scholar 

  26. Markowitz S., Saito K. and Moskowitz M.A.: J. Neurosci. 7, 4129–4136 (1987).

    PubMed  CAS  Google Scholar 

  27. Moskowitz M.A.: Neurology 41, 182–186 (1991).

    PubMed  CAS  Google Scholar 

  28. Ray B.S. and Wolff H.G.: Arch. Surg. 41, 813–856 (1940).

    Google Scholar 

  29. Goadsby P.J., Zagami A.S. and Lambert G.A.: Headache 31, 365–371 (1991).

    PubMed  CAS  Google Scholar 

  30. Goadsby P.J., Edvinsson L. and Ekman R.: Ann. Neurol. 23, 193–196 (1988).

    PubMed  CAS  Google Scholar 

  31. Moskowitz M.A., Lee W.S. and Cutrer E.M., in: P. Geppetti and P. Holzer (eds.): Neurogenic Inflammation, CRC Press, New York 1996, 187–199.

    Google Scholar 

  32. Beattie D.T., McNeil D.K. and Connor H.E.: Neuropeptides 213, 228–230 (1993).

    Google Scholar 

  33. Dimitriadou V., Buzzi M.G., Moskowitz M.A. and Theoharides T.C.: Neuroscience 44, 97–112 (1991).

    PubMed  CAS  Google Scholar 

  34. Dimitriadou V., Buzzi M.G., Theoharides T.C. and Moskowitz M.A.: Neuroscience 48, 187–203 (1992).

    PubMed  CAS  Google Scholar 

  35. Brain S.D. and Williams T.J.: Br. J. Pharmacol. 86, 855–860 (1985).

    PubMed  CAS  Google Scholar 

  36. Le Greves P., Nyberg F., Terenius L. and Hokfelt T.: Eur. J. Pharmacol. 115, 309–311 (1985).

    PubMed  CAS  Google Scholar 

  37. Olesen J., Thomsen L.L. and Iversen H.K.: Trends Pharmacol. Sci. 15, 149–153 (1994).

    PubMed  CAS  Google Scholar 

  38. Olesen J., Inversen H.K. and Thomsen L.L.: Neuroreport 4, 1027–1030 (1993).

    PubMed  CAS  Google Scholar 

  39. Thomsen L.L., Kruuse C., Iversen H.K. and Olesen J.: Eur. J. Neurol. 1, 73–80 (1994).

    Google Scholar 

  40. Lassen L.H., Ashina M., Christiansen I., Ulrich F. and Olesen J.: Lancet 349, 401–402 (1997).

    PubMed  CAS  Google Scholar 

  41. Fozard J.R.: Arch. Int. Pharmacodyn. 329, 111–119 (1995).

    PubMed  CAS  Google Scholar 

  42. Jeffrey S.R. and Snyder S.H.: Ann. Rev. Cell Dev Biol. 11, 417–440 (1995).

    Google Scholar 

  43. Schmuck K., Ullmer C., Kalkman H.O., Probst A. and Lubbert H.: Eur. J. Neurosci. 8, 959–967 (1996).

    PubMed  CAS  Google Scholar 

  44. Humphrey P.P., Feniuk W., Perren M.J., Connor H.E., Oxford A.W., Coates L.H. and Butina D.: Br. J. Pharmacol. 94, 1123–1132 (1988).

    PubMed  CAS  Google Scholar 

  45. Humphrey P.P., Feniuk W., Perren M.J., Connor H.E. and Oxford A.W.: Cephalalgia Suppl. 9, 23–33 (1989).

    Google Scholar 

  46. Peroutka S.J. and McCarthy B.G.: Eur. J. Pharmacol. 163, 133–136 (1989).

    PubMed  CAS  Google Scholar 

  47. Humphrey P.P., Feniuk W. and Perren M.J.: Headache 30, 12–16 (1990).

    PubMed  CAS  Google Scholar 

  48. Deliganis A.V. and Peroutka S.J.: Headache 336, 228–231 (1991).

    Google Scholar 

  49. Weinshank R.L., Zgombick J.M., Macchi M.J., Branchek T.A. and Hartig P.R.: Proc. Natl. Acad. Sci. USA 89, 3630–3634 (1992).

    PubMed  CAS  Google Scholar 

  50. Adham N., Kao H.T., Schecter L.E., Bard J., Olsen M., Urquhart D., Durkin M., Hartig R.R., Weinshank R.L. and Branchek T.A.: Proc. Natl. Acad. Sci. USA 90, 408–412 (1993).

    PubMed  CAS  Google Scholar 

  51. Pascual J., Arco C.D., Romon T., Olmo E.D. and Pazos A.: Eur. J. Pharmacol. 295, 271–274 (1996).

    PubMed  CAS  Google Scholar 

  52. Bouchelet I., Cohen Z., Case B., Seguela P. and Hamel E.: Mol. Pharmacol. 50, 219–223 (1996).

    PubMed  CAS  Google Scholar 

  53. Johnson K.W., Schaus J.M., Durkin M.M., Audia J.E., Kaldor S.W., Flaugh M.E., Adham N., Zgombick J.M., Cohen M.L., Branchek T.A. and Phebus L.A.: NeuroReport 8, 2237–2240 (1997).

    PubMed  CAS  Google Scholar 

  54. Cohen M.L., Johnson K.W., Schenck K.W. and Phebus L.A.: Cephalalgia 17, 631–638 (1997).

    PubMed  CAS  Google Scholar 

  55. Willett F., Curven N., Adams J. and Armitage M.: Br. Med. J. 304, 1415 (1992).

    CAS  Google Scholar 

  56. Hillis W.S. and Maclntyre P.D.: Lancet 341, 1564–1565 (1993).

    PubMed  CAS  Google Scholar 

  57. Ottervanger J.P., Paalman H.J., Boxma G.L. and Stricker B.H.: Lancet 341, 861–862 (1993).

    PubMed  CAS  Google Scholar 

  58. Kalkman H.O.: Life Sci 54, 641–644 (1994).

    PubMed  CAS  Google Scholar 

  59. Johnson K.W., Nelson D.L., Wainscott D.B., Lucaites V.L. and Phebus L.A.: Cephalalgia 17, 342 (1997).

    Google Scholar 

  60. Meyer J.S., Hata T. and Miai A., in: J.N. Blau (ed.): Migraine-therapeutic, conceptual and research aspects. Elsevier, Amsterdam 1987, pp. 265–302.

    Google Scholar 

  61. Heyck H.: Res. Clin. Stud. Headache 22, 1–28 (1969).

    Google Scholar 

  62. Saxena P.R. and Verdouw P.D.: J. Physiol. (Lond.) 332, 501–520 (1982).

    CAS  Google Scholar 

  63. Saxena P.R., DeVries P., Heiligers J.P.C., VanDenBrink A.M., Bax W.A., Barv T. and Wikstrom H.: Eur. J. Pharmacol. 312, 53–62 (1996).

    PubMed  CAS  Google Scholar 

  64. Saxena R.R., VanDenBrink A.M., Heiligers J.P.C., Scalbert E. and Lemaitre B.G.: Pharmacol. & Toxicol. 79, 199–204 (1996).

    CAS  Google Scholar 

  65. Saxena P.R., DeBriew P., Wang W., Heiligers J.P.C., VanDenBrink A.M., Bax W.A. and Yocca F.D.: Naunyn Schmiedeberg’s Arch. Pharmacol. 355, 295–302 (1997).

    CAS  Google Scholar 

  66. Perren M.J., Feniuk W. and Humphrey P.P.A.: Cephalalgia 9S, 41–46 (1989).

    Google Scholar 

  67. Buzzi M.G. and Moskowitz M.A.: Br. J. Pharmacol. 99, 202–206 (1990).

    PubMed  CAS  Google Scholar 

  68. Connor H.E., Feniuk W. and Beattie D.T.: Cephalalgia 17, 145–152 (1997).

    PubMed  CAS  Google Scholar 

  69. Martin G.R., Robertson A.D., MacLennan S.J., Prentice D.J., Barrett V.J., Buckingham J., Honey A.C., Giles H. and Moneada S.: Br. J. Pharmacol. 121, 157–164 (1997).

    PubMed  CAS  Google Scholar 

  70. Brewerton T.D., Murphy D.L., Mueller E.A. and Jimmerson D.C.: Clin. Pharmacol. Ther. 43, 605–609 (1988).

    PubMed  CAS  Google Scholar 

  71. Fuller R.W., Kurz K.D., Mason N.R. and Cohen M.L.: Eur. J. Pharmacol. 125, 71–77 (1986).

    PubMed  CAS  Google Scholar 

  72. Nelson D.L., Wainscott D.B., Lucaites V.L., Calligaro D.O., Zgombick J.M., Audia J.E., Phebus L.A., and Johnson K.W.: Cephalalgia 17, 341–342 (1997).

    Google Scholar 

  73. Nozaki K., Boccalini P. and Moskowitz M.A.: Neurosci. 49, 669–680 (1992).

    CAS  Google Scholar 

  74. Nozaki K., Moskowitz M.A. and Boccalini P.: Br. J. Pharmacol. 106, 409–415 (1992).

    PubMed  CAS  Google Scholar 

  75. Kaube H., Keay K.A., Hoskin K.L., Bandler R. and Goadsby P.J.: Brain Res. 629, 95–102 (1993).

    PubMed  CAS  Google Scholar 

  76. Shepheard S.L., Williamson D.J., Williams J., Hill R.G. and Hargreaves R.J.: Neuropharmacol. 34, 255–261 (1995).

    CAS  Google Scholar 

  77. Buzzi M.G., Sajas D.E. and Moskowitz M.A.: Eur. J. Pharmacol. 165, 251–258 (1989).

    PubMed  CAS  Google Scholar 

  78. Buzzi M.G., Moskowitz M.A., Peroutka S.J. and Byun B.: Br. J. Pharmacol. 103, 1421–1428 (1991).

    PubMed  CAS  Google Scholar 

  79. Curtin T., Brooks A.P. and Roberts J.A.: Br. Med. J. 305, 713–714 (1992).

    CAS  Google Scholar 

  80. Luman W. and Gray R.S.: Lancet 341, 1091–1092 (1993).

    PubMed  CAS  Google Scholar 

  81. Cavazos J.E., Caress J.B., Chilukuri V.R., Devlin T., Gray L. and Hurwitz B.J.: Lancet 343, 1105–1106 (1994).

    PubMed  CAS  Google Scholar 

  82. Cady R.K., Wendt J.K., Kirchner J.R., Sargent J.D., Rothrock J.F. and Skaggs H.: JAMA 165, 2831–2835 (1991).

    Google Scholar 

  83. Tfelt-Hansen P.: Cephalalgia 13, 238–244 (1993).

    PubMed  CAS  Google Scholar 

  84. Dahlof C., in: J. Olese (ed.): Frontiers in Headache Research Vol 6. Headache Treatment Trial Methodology and New Drugs. Lippencott-Raven Publishers, Philadelphia 1997, pp. 243–251.

    Google Scholar 

  85. Bates D., Ashford E., Dawson R., Ensink F.B., Gilhus N.E., Olesen J., Pilgrim A.J. and Shevlin P.: Neurol. 44, 1587–1592 (1994).

    CAS  Google Scholar 

  86. Phebus L.A., Johnson K.W., Zgombick J.M., Gilbert P.J., VanBelle K., Mancusco V., Nelson D.L.G., Calligaro D.O., Kiefer A.D., Branchek T.A. and Flaugh M.E.: Life Sci. 61, 2117–2126 (1997).

    PubMed  CAS  Google Scholar 

  87. Yu X.J., Waeber C., Castanon N., Scearce K., Hen R., Macor J.E., Chauveau J. and Moskowitz M.A.: Mol. Pharmacol. 49, 761–765 (1996).

    PubMed  CAS  Google Scholar 

  88. Forbes I.T., Kennet G.A., Gadre A., Ham P., Hayward C., Martin J., Thompson R.T., Wood M., Baxter M.D., Glen G.S., Murphy O.E., Steward B.R. and Blackburn T.P.: J. Med. Chem. 36, 1104 (1993).

    PubMed  CAS  Google Scholar 

  89. Forbes I.T., Ham P., Booth D.H., Martin R.T., Thompson M., Baxter G.S., Blackburn T.P., Glen A., Kennett G.A. and Wood M.D.: J. Med. Chem. 38, 2524–2530 (1995).

    PubMed  CAS  Google Scholar 

  90. Forbes I.T., Jones G.E., Murphy O.E., Holland V. and Baxter G.S.: J. Med. Chem. 38(6), 855–857 (1995).

    PubMed  CAS  Google Scholar 

  91. Bonhaus D.W., Bach C., DeSouza A., Salazar F.H.R., Matsuoka B.D., Zuppan P., Chan H.W. and Eglen R.M.: Br. J. Pharmacol. 115, 622–628 (1995).

    PubMed  CAS  Google Scholar 

  92. Thomas D.R., Baxter G.S., Carey J.E., Gager T.L., Gale D.G., Holland V., Muir A., Wilson S. and Wood M.D.: Br. J. Pharmacol. 117, 137P (1996).

    Google Scholar 

  93. Nozulak J., Kalkman H.O., Floersheim P., Hoyer D., Schoeffler P. and Buerki H.R.: J. Med. Chem. 38, 28–33 (1995).

    PubMed  CAS  Google Scholar 

  94. Cohen M.L., Audia J. and Nelson D.: ID Research Alert-Serotonin 2, 1–5 (1997).

    Google Scholar 

  95. Cohen M.L., Schenck K.W., Mabry T.E., Nelson D.L. and Audia J.E.: J. Serotonin Res. 3, 131–144 (1996).

    CAS  Google Scholar 

  96. Leysen J.E., Gommeren W., Heylen L., Luyten W.H.M.L., Van De Weyer I., Vanhoenacker P., Haegeman G., Schotte A., Van Gompel P., Wouters R. and Lesage A.S.: Mol. Pharmacol. 50, 1567–1580 (1996).

    PubMed  CAS  Google Scholar 

  97. Domenech T., Beleta J. and Palacios J.M.: Naunyn Schmiedebergs Arch. Pharmacol. 356, 328–334 (1997).

    PubMed  CAS  Google Scholar 

  98. Wurch T., Cathala C., Palmier C., Valentin J.P., John G.W., Colpaert F.C. and Pauwels P.J.: Neurosci. Res. Comm. 18, 155–162 (1996).

    CAS  Google Scholar 

  99. Wurch T., Palmier C., Colpaert F.C. and Pauwels P.J.: J. Neurochem. 68, 410–418 (1997).

    PubMed  CAS  Google Scholar 

  100. Yocca F.D., Buchanan J., Gylys J.A., Hamel E., Iben L.G., Izzarelli D.G., Mahle C.D., Myers R., Noonan J.W., Parker E.M., Williams A.D., Sarbin N., Saxena P., Smith D.W. and Wiener H.L.: Cephalalgia 15, 174 (1995).

    Google Scholar 

  101. Gupta P., Napier C.M., Scatchard J., Shepperson N.B. and Wallis R.: Cephalalgia 17, 413 (1997).

    Google Scholar 

  102. Yocca F.D., Gylys J.A., Smith D.W., Ruediger E., Yevich J.P., Mahle C., Wiener H., Marcus R., Smith J., Saxena P. and Moskowitz M.: Cephalalgia 17, 404 (1997).

    Google Scholar 

  103. The Subcutaneous Sumatriptan International Study Group (1991): N. Engl. J. Med. 325, 316–321.

    Google Scholar 

  104. Fowler P.A., Lacey L.F., Thomas M., Keene O.N., Tanner R.J.N., and Baber N.S.: Eur. Neurol. 31, 291–294 (1991).

    PubMed  CAS  Google Scholar 

  105. Cady R.K., Rubino, J., Crummett D. and Littlejohn III T.W.: Arch. Fam. Med. 3(9), 766–772 (1994).

    PubMed  CAS  Google Scholar 

  106. Sheftell F.D., Weeks R.E., Rapoport A.M., Siegel S., Baskin S. and Arrowsmith F.: Headache 34, 67–72 (1994).

    PubMed  CAS  Google Scholar 

  107. Lloyd K.: Eur. Neurol. 34, 40–43 (1994).

    PubMed  Google Scholar 

  108. Visser W.H.: 5-HT1 receptor agonists in the acute treatment of migraine. Clinical, epidemiological and pharmacological aspects. Eburon-Delft, Delft 1996.

    Google Scholar 

  109. Ferrari M.D., James M.H., Bates D., Pilgrim A.J., Ashford E.A., Anderson B. and Nappi G.: Cephalalgia 14, 330–338 (1994).

    PubMed  CAS  Google Scholar 

  110. Ferrari M.D., Martin G.R., Earl N.L. and Klein K.B.: Eur. Neurol. 36(Suppl2), 19–23 (1996).

    PubMed  CAS  Google Scholar 

  111. Zagami A.S.: Neurology 48(3), S25–S28 (1997).

    PubMed  CAS  Google Scholar 

  112. Solomon G.D., Cady R.K., Klapper J.A., Earl N.L., Saper J.R. and Ramadan N.M.: Neurology 49(5), 1219–1225 (1997).

    PubMed  CAS  Google Scholar 

  113. Gunasekara N.S. and Wiseman, L.R.: CNS Drugs 8(5), 402–408 (1997).

    CAS  Google Scholar 

  114. Gijsman H., Kramer M.S., Sargent J., Tuchman M., Matzura-Wolfe D., Polis A., Teall J., Block G. and Ferrari M.D.: Cephalalgia 17(6), 647–651 (1997).

    PubMed  CAS  Google Scholar 

  115. Sciberras D.G., Polvina W.J., Gertz B.J., Cheng H., Stepanavage M., Wittreich J., Olah T., Edwards M. and Mant T.: Br. J. Clin. Pharamcol. 43, 49–54 (1997).

    CAS  Google Scholar 

  116. Visser W.H., Terwindt G.M., Reines S.A., Jiang K., Lines C.R. and Ferrari M.D.: Arch Neurol. 53(11), 1132–1137(1996).

    PubMed  CAS  Google Scholar 

  117. Schoen J.: Curr. Opin. Neurol. 10, 237–243 (1997).

    Google Scholar 

  118. Jackson N.C. for the Eletriptan Steering Committee: Cephalalgia 16, 368 (1996).

    Google Scholar 

  119. Cabarrocas X. and Salva M.: Cephalalgia 17, 421 (1997).

    Google Scholar 

  120. Goldstein J., Schellens R., Diener H.C., Dahlof C., Olesen J., Senard J.M., Steiner T.J. and Simard D., in: J. Olesen, P. Tfelt-Hansen (eds.): Headache treatment, trial methodology and new drugs. Lippincott-Raven Publishers, Philadelphia 1997, pp. 279–285.

    Google Scholar 

  121. Diener H.C., Gendolla A., Juptner M., Kaube H. and Limmroth V: Eur Neurol. 38, 167–174 (1997).

    PubMed  CAS  Google Scholar 

  122. Mathew N.T., in: N.T. Mathew (ed.): Advances in Headache. W.B. Saunders Company, Philadelphia 1997, vol. 15(1), 61–83.

    Google Scholar 

  123. Winner P., Ricalde O., Le Force B., Saper J., and Margul B.: Arch. Neurol. 53, 180–184 (1996).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Drop Code 0520, Indianapolis, IN, 46285, USA

    Kirk W. Johnson, Lee A. Phebus & Marlene L. Cohen

Authors
  1. Kirk W. Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lee A. Phebus
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marlene L. Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Steinweg 28, CH-4107, Ettingen, Switzerland

    Ernst Jucker

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Basel AG

About this chapter

Cite this chapter

Johnson, K.W., Phebus, L.A., Cohen, M.L. (1998). Serotonin in migraine: Theories, animal models and emerging therapies. In: Jucker, E. (eds) Progress in Drug Research. Progress in Drug Research, vol 51. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8845-5_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-8845-5_6

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-9798-3

  • Online ISBN: 978-3-0348-8845-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation